SCHEMBL22041595

SCHEMBL22041595

O=C(Oc1c(Cl)c(Cl)cc2cc(C(=O)O)c(=O)oc12)c1cccs1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 10/20 0.47
▸ HPGD P15428 4/20 0.45
▸ USP2 O75604 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ ALOX12 P18054 1/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ CASP7 P55210 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ ALDH1A1 P00352 6/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ GLA P06280 2/20 0.42
▸ GAA P10253 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ LMNA P02545 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ HSP90AA1 P07900 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22041622 0.83 GPR35 (0.51) GPR35HPGDALDH1A1KDM4EGLA
SCHEMBL22041628 0.81 GPR35 (0.47) GPR35HPGDUSP2POLBALOX15
SCHEMBL22041598 0.78 GPR35 (0.55) GPR35HPGDUSP2POLBALOX15
SCHEMBL22041638 0.77 GPR35 (0.52) GPR35HPGDALDH1A1KDM4EGLA
SCHEMBL22041606 0.70 GPR35 (0.71) GPR35HPGDUSP2POLBALOX15
SCHEMBL22041599 0.69 GPR35 (0.52) GPR35HPGDUSP2POLBALOX15
SCHEMBL18306420 0.66 MAOA (0.71) GPR35HPGDUSP2POLBALOX15
SCHEMBL11532310 0.65 MAPT (0.48) GPR35HPGDUSP2POLBALOX15
SCHEMBL22041603 0.65 GPR35 (0.53) GPR35MAOACA12CA1CA2
SCHEMBL22041589 0.65 GPR35 (0.50) GPR35HPGDUSP2POLBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111285790-A 3-carboxycoumarin derivative capable of serving as GPR35 agonist, preparation method and application 泰州医药城国科化物生物医药科技有限公司 2020-06-16 — — CN claimed
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 — — WO claimed
CN-111285790-A 3-carboxycoumarin derivative capable of serving as GPR35 agonist, preparation method and application 泰州医药城国科化物生物医药科技有限公司 2020-06-16 — — CN disclosed
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 — — WO disclosed
Send feedback